News

Peter A. McCullough, a former cardiologist who promoted unproven treatments like ivermectin and hydroxychloroquine at the ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
The Food and Drug Administration has outlined new regulations for COVID-19 booster shots, setting stricter approval standards ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
O n May 20, the federal government announced a major shift in how it plans to review and recommend COVID-19 vaccines for Americans. Among the changes: when manufacturers want to u ...
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis.
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate ...
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...
Though the new FDA rules limit access to COVID-19 booster vaccines, the commitment to high-risk groups lifts Moderna, Pfizer ...